Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1380.30

-13.80 (-0.99%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1380.30

-13.80 (-0.99%)
16:02 Dec 20

Quality

43/100
Medium Financial Strength

Valuation

23/100
Expensive Valuation

Technical

59/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1211.86	1347.04	1685.15	2009.14	2495.89
Operating Expenses +	781.29	862.09	1148.4	1334.32	1659.68
Raw Material	276.44	259.29	348.53	379.33	581.17
Increase Decrease in Cost	-38.17	-0.78	3.82	0.72	-7.26
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	229.3	252.25	346.16	403.82	459.41
Miscellaneous Expenses	667.74	634.77	862.55	953.49	626.36
Operating Profit	430.57	484.95	536.75	674.82	836.21
Other Income	8.71	26.09	11.15	23.82	27.76
Depreciation	42.98	64.7	117.09	182.6	256.04
Interest	1.8	4.15	26.17	84.8	170.99
Profit before tax and exceptio..	394.5	442.2	404.64	431.24	436.94
Exceptional Items	0	0	0	0	0
PBT	394.5	442.2	404.64	431.24	436.94
Provision for Taxation	39.36	36.41	30.48	34.18	70.08
Net Profit	355.14	405.79	374.16	397.05	366.86
NET Profit after MI	355.14	406.11	382.16	391.98	348.47
EPS	26.14	29.89	28.1	28.82	25.61
Operating Profit Margin (%)	35.53	36	31.85	33.59	33.5
Net Profit Margin (%)	29.31	30.15	22.68	19.51	13.96

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	54.90	54.90	54.90	54.90	54.90
FII	8.00	14.60	14.30	13.10	13.20
MF	17.00	14.50	14.90	13.80	13.90
Public	18.50	14.30	15.20	17.40	17.40
Others	0.00	0.00	0.00	0.00	0.00
Others	1.60	1.70	0.70	0.80	0.60